Cognitive impairment is a significant and often debilitating aspect of schizophrenia, affecting various cognitive domains such as memory, attention, and processing speed. These deficits are not ...

Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has submitted a Letter of Intent to the U.S. Food ...

Cognitive issues are core symptoms of schizophrenia. More than 80 percent of people with schizophrenia have cognitive ...

The University of Bath has received a £3.5 million Wellcome grant to study cognitive decline and premature brain ageing in ...

For information, the company have advised that they are no longer pursuing a Marketing Authorisation Application from the Medicines and Healthcare products Regulatory Agency (MHRA) for this indication ...

[2] It therefore appears likely that cocaine exacerbates existing cognitive impairment in schizophrenia. To date, the effects of cocaine abuse on cognitive functioning in schizophrenic individuals ...

Schizophrenia is a serious mental disorder ... but it could also reflect a more generalized cognitive impairment, such as attention lapses, which could be estimated by the proportion of errors ...

Schizophrenia symptoms include ... Other symptoms, such as cognitive impairment – problems with attention, concentration, memory and declining educational performance – and mood issues ...

Our gratitude goes to the patients and clinical investigators whose time and commitment made this research possible.” CONNEX was the largest program for cognitive impairment in schizophrenia to date.

Iclepertin was anticipated to be effective for schizophrenia with cognitive impairment due to its effect of inhibiting glycine transporter type 1 (GlyT1). The U.S. Food and Drug Administration ...